Shandong Wohua Pharmaceutical Co. Ltd. | Ownership
Companies that own Shandong Wohua Pharmaceutical Co. Ltd.
Chang Xin Asset Management Co., Ltd.
9,309,034
2.67%
9,309,034
0.42%
12/31/2016
Penghua Fund Management Co., Ltd.
1,499,962
0.43%
1,499,962
0.02%
12/31/2016
China Universal Asset Management Co., Ltd.
1,499,862
0.43%
1,499,862
0.01%
12/31/2016
Guotai Asset Management Co., Ltd.
1,327,402
0.38%
1,327,402
0.02%
12/31/2016
The Vanguard Group, Inc.
238,400
0.07%
0
0%
07/31/2018
GF Fund Management Co., Ltd.
109,136
0.03%
10,800
0%
12/31/2017
Guotai Junan Allianz Fund Management Co., Ltd.
1,069
0%
0
0%
12/31/2017
Zhongrong Fund Management Co. Ltd.
0
0%
-106,800
0%
12/31/2017
Lion Fund Management Co., Ltd.
0
0%
-4,198
0%
12/31/2017
Bank of China Investment Management Co., Ltd.
0
0%
-169,600
0%
12/31/2017
| Address |
No. 3517 Liyuan Street
Weifang Shandong 261205
China
|
|
Employees
|
- |
| Website |
http://www.wohua.cn |
| Updated |
07/08/2019 |
| Shandong Wohua Pharmaceutical Co., Ltd. engages in the manufacture and sale of cardiovascular and cerebrovascular Chinese medicines. Its products include tablets and herbal medicines for respiratory, women and children, urinary system, body heat clearing, digestive system, and anti rheumatism. The company was founded on March 25, 2003 and is headquartered in Weifang, China. |
